About CMC Biologics
CMC Biologics is a company based in Copenhagen (Denmark) founded in 2001 was acquired by AGC in December 2016. The company has 1,264 employees as of March 31, 2024. CMC Biologics operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
- Headquarter Copenhagen, Denmark
- Employees 1264 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Agc Biologics A/S
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CMC Biologics
Investors in CMC Biologics
CMC Biologics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include AGC, Monitor Clipper Partners and European Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Monitor Clipper Partners is engaged in middle-market private equity investments.
|
Locked | Locked | Locked | |
|
Investment in life sciences companies is facilitated by EEP.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for CMC Biologics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CMC Biologics
Investment portfolio details for CMC Biologics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CMC Biologics
Detailed financials for CMC Biologics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cmc Biologics Comparisons
Peer comparison for CMC Biologics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CMC Biologics
CMC Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| Locked | Locked | Locked |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| Locked | Locked | Locked |
Integrated biologics development and manufacturing are provided as a CDMO.
|
|
| Locked | Locked | Locked |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| Locked | Locked | Locked |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| Locked | Locked | Locked |
Precision fermentation services for biopharma and food are provided.
|
Detailed competitors of CMC Biologics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cmc Biologics
Complete news archive for CMC Biologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CMC Biologics
CMC Biologics was founded in 2001 and raised its 1st funding round 3 years after it was founded.
CMC Biologics is headquartered in Copenhagen, Denmark.
As of Mar 31, 2024, the latest employee count at CMC Biologics is 1,264.
Annual revenue of CMC Biologics is $55.44M as on Dec 31, 2014.
CMC Biologics provides biopharmaceutical contract manufacturing services. It offers microbial fermentation and mammalian cell culture based cGMP manufacturing services, such as process development and scale-up of protein processes; and production of biopharmaceuticals for pre-clinical, clinical trials, and market supply. CMC Biologics claims to be one of the few CDMOs that are capable of offering mammalian perfusion production services which include BioSEP, ATF and other perfusion technologies. CMC Biologics also has a proprietary CHEF1 Expression Platform for quicker and effective development through mammalian cell lines. The company also provides consultancy in facility design, quality, and regulatory issues; technology evaluation, analytical development and quality control services. The company has FDA MHRA approved manufacturing facilities (with both single-use and stainless steel bioreactors) in Copenhagen, Seattle and Berkeley and claims to have completed 120 projects right from preclinical supply to commercial production. The company was acquired by Japans AGC Asahi Glass in December 2016.
CMC Biologics's top competitors include KBI Biopharma, Aldevron and Ovagen.
CMC Biologics has 4 investors. Key investors include AGC, Monitor Clipper Partners, European Equity Partners, and Innoven Partners.